Abu Dhabi’s DoH signs pharma pact with ADIO and Etihad
Now Reading
Abu Dhabi’s DoH partners with ADIO, Etihad Airways to boost pharma capabilities

Abu Dhabi’s DoH partners with ADIO, Etihad Airways to boost pharma capabilities

The government-backed entities seek to leverage the emirate’s strategic location, lucrative investment opportunities and advanced logistics capabilities

Kudakwashe Muzoriwa
Abu Dhabi’s DoH partners with ADIO and Etihad Airways to boost pharma capabilities

The Department of Health – Abu Dhabi (DoH) has partnered with three government-backed entities to bolster the emirate’s capabilities as a global pharmaceutical and life sciences distribution hub.

The partnership between the DoH, ADIO, Etihad Airways and AD Ports Group aims to create attractive value propositions for pharmaceutical, biotechnology, and medical technology companies to establish their operations in Abu Dhabi.

The government-backed entities seek to leverage the emirate’s strategic location, lucrative investment opportunities and advanced logistics capabilities in line with the Abu Dhabi Economic Vision 2030.

“Leveraging Abu Dhabi’s strategic location at the gateway to the MENA region, we are partnering with world-class leaders in investment and logistics, offering advanced infrastructure with easy access to regional and global markets,” said Dr Asma Ibrahim Al Mannaei, executive director of the Research and Innovation Centre at DoH.

“By establishing a robust healthcare and life-science distribution hub, we are poised to enhance healthcare outcomes and improve lives across the region.”

The pharma and biotech companies will capitalise on DoH’s world-class regulatory framework, ADIO’s attractive investment platform, Etihad Cargo’s expertise in air freight, and AD Port’s robust logistics infrastructure.

The DoH, ADIO, Etihad and AD Ports agreed to collaborate to ensure timely access to innovative healthcare products for patients across the Middle East region while advancing Abu Dhabi’s role in global pharmaceutical supply chains.

“The partnership will enhance Abu Dhabi’s regional and global competitiveness and ensure timely access to innovative healthcare products by leveraging KEZAD Group’s strategic location, world-class logistics infrastructure, and robust investment environment,” said Mansoor Al Marar, vice president of industrial Business Development at KEZAD Group.

The collaboration, which is aligned with Abu Dhabi’s economic aspirations, is expected to attract significant investment in healthcare and logistics, promoting sustainable economic growth and diversification within the healthcare and life sciences sectors.

The DoH, ADIO, Etihad and AD Ports also seek to bolster local manufacturing and packaging capabilities.

A high-profile Abu Dhabi delegation, led by the DoH, visited the US from May 29 to  June 5 to showcase the city’s capabilities and explore collaboration in research and development (R&D), manufacturing and innovation.

Read: Mumtalakat, M42 to launch Amana Healthcare in Bahrain

You might also like


© 2021 MOTIVATE MEDIA GROUP. ALL RIGHTS RESERVED.

Scroll To Top